「新產品研發」對於技術推動的製葯產業，是企業的一項重要功能。探討研發管 理的文獻，鮮少就研發的不同類型予以探討其管理方式，本研究彙總整理了過去有關研發類 型之分類方式，並針對臺灣製藥業研發之特性，提出「技術風險度」、與「市場複雜度」兩 構面，形成了八種不同研發類型之分類方式。 作者並從臺灣區製藥工業同業公會，挑選出技術績效最佳之十五家藥廠，做為本研究之樣本進行 個案之深入訪談，探討其研發類型與研發管理機制之間的關係。研究結果發現，愈傾向於高 創新度之研發類型廠商，其管理方式愈傾向於有正式研發組織、聘用高學歷之研發人員、採 用較授權、Y 理論之研發領導、研發過程中在研發 / 行銷、研發 / 製造介面之間的溝通較頻 繁、公司在研發投資之研發強度亦較高；反之，愈傾向於低創新度之研發類型廠商，其管理方 式卻有相反的結果，管理中的權變理論在此得到印證

　　　　　R&D Activity is a Critical Function in Most Technology-Push Industry L ike Pharmaceuticals Industry, Suitable R&D Management Will be Helpful for R&D Performance, But Few Studies Have Specifically Considered about the Different R&D Type. In This paper, the Author Reviewed the Related Literature about R&D Taxonomy Method, and Set Up a Special Taxonomy Matrix for Taiwan Pharmaceutical R&D which Has Two Taxonomy Dimension by "Technology Riskiness" and "Market Comp lexity:. the Author Selected 15 High R&D Performance Company among Taiwan Pharm aceutical Industry to Make a In-Depth Interview with R&D head and R&D Staff. Th is Study Have Some Interesting Finding That Different Type of R&D Will Have Dif ferent Management Mechanism Thus Will have Better R&D Performance, the Continge ncy theory of Management is Certified Here.